Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human myeloid derived suppressor cell cancer markers

Human myeloid derived suppressor cell cancer markers

US Patent 8883497 · Granted Nov 11, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2025
Lym-1 and Lym-2 antibody compositions and improved car constructs2023
Humanized anti-nuclear antibodies for targeting necrosis in cancer therapy2022
Car t-cell therapy directed to LHR for the treatment of solid tumors2021
CD20 scFv-ELPs methods and therapeutics2021
Lym-1 and Lym-2 targeted CAR cell immunotherapy2020
OX40L fusion protein for the immunotherapy of tumors of veterinary animals2019
Human myeloid derived suppressor cell cancer markers2017
Human myeloid derived suppressor cell cancer markers2017
Cancer targeted innate immunity2016
Compositions and methods for cancer immunotherapy2014
Compositions and methods for cancer immunotherapy2013